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Background
Since mid-sixties, the association between miasthenia
gravis, tymectomia for the disease control, and devel-
opment of autoimmune disorders (i.e. systemic lupus
erythematosus, ulcerative cholitis, rheumatoid arthritis,
lichen planus), is known, while the relationship with
the occurrence of systemic infectious complications is
less lnown (underlying immunodeficiency, jatrogenic
immunosuppression?).
Methods
A 26-y-old female patient (p), with a post-thyroiditis
hypotireodism, polycystic oophoritis, and a diagnosis of
myasthenia gravis posed 4 y before, developed an ileal-
colonic Chron’s disease treated since 2 mo with
steroids.
Results
When moved to our Infectious Disease Division due to
septic hyperpyrexia, not responsive to an initial empiric
antimicrobial therapy, and with a presumed allergic-
toxic rash, underwent a further workup. An evident leu-
kocyotosis (WBC 23,550/μL,88.3% neutrophils), was
associated with increased ESR (86), mild hepatocytolisis,
hemorrhagic conjunctivitis, and nodular erythema at
lower limbs. An ultrasonographic-CT scan suggested a
multifocal pyelonephritis, comfirmed by the isolation of
E. coli at urinalysis. Combined, full-dose i.v. cefotaxime-
metronidazole, was changed upon discharge with
ciprofloxacin, and with the reintroduction of steroideal
therapy for Chron’s disease.
Discussion
A large number of predisposing conditions make sub-
jects suffering from autoimmune/dysreactive disorders
prone to develop even severe infectious complications,
including the frequent immunosuppressive therapies,
and the multiple immunodeficiencies detected at the
time of diagnosis of these conditions. In the reported p,
an autoimmune thryroiditis, a myasthenia gravis, a
Crohn’s disease, and an erytema nodosum were dis-
closed in a young female p aged 26. Consultants
requested of diagnosis and management of complica-
tions, should take into consideration the heterogeneic,
systemic background of each disease presentation, and
their possible complications, with a proportionally ele-
vated risk of infectious diseases, which take advantage
from the chronic administration of steroids or other
immunosuppressive drugs, and the unbalanced immune
system, usually shifted towards a Th1 response, which
tends to balance the increased Th2 activity typical of
autoimmune disorders. As known, p with chronic
inflammatory bowel diseases suffer from myasthenia
gravis with a greater frequency vs the general popula-
tion. From a pathogenetic point of view, the intrathymic
maturation process of T-lymphocytes is altered during
myasthenia gravis, while intyrathymic B-lymphocyte
abnormalities may contribute to the onset of autoim-
mune disorders. In cases likeo u r s ,t h ec o n c u r r e n c eo f
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© 2010 Manfredi; licensee BioMed Central Ltd.multiple disorders may complicate the differential diag-
nosis, and hamper a prompt recognition and manage-
ment of potentially severe infectious complications.
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